Hospital Sao Rafael   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Salvador Brazil (1990)

Organization Overview

First Clinical Trial
2015
NCT02152657
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Hospital Sao Rafael | Hospital São Rafael | Hospital São Rafael S.A

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cardiomyopathies (Phase 2)

Chagas Cardiomyopathy (Phase 2)

Fibrosis (Phase 2)

Hepatitis (Phase 2)

Hepatitis, Chronic (Phase 2)

Inflammation (Phase 2)

Kidney Diseases (Phase 2)

Liver Cirrhosis (Phase 2)

Liver Diseases (Phase 2)

Myocarditis (Phase 2)

Renal Insufficiency, Chronic (Phase 2)

Spinal Cord Injuries (Phase 2)

Wounds and Injuries (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 7